Skip to main content
⚠️Research Notice: This information is for educational and laboratory research purposes only. Not for human consumption.
GHRH Familymedium Confidence

CJC-1295 (With DAC)

Last Updated: December 2025
Use in Calculator

Key Takeaways: CJC-1295 (With DAC)

CJC-1295 (With DAC) is a GHRH peptide primarily researched for:

  • Increased growth hormone levels
  • GH-axis research interest
  • Recovery research interest

Research Profile

Stability ClassStandard
Confidencemedium
Freezable?❌ No (Fragile)

CJC-1295 (With DAC) is a modified GHRH analog that includes a Drug Affinity Complex (DAC) to extend its half-life and produce more sustained growth hormone signaling.

DAC vs No DAC

There are two primary forms:

  1. CJC-1295 No DAC (MOD GRF 1-29): Shorter half-life (~30 mins), allows for more natural “pulses” of growth hormone.
  2. CJC-1295 With DAC: Includes Drug Affinity Complex to extend half-life to several days, providing continuous GH elevation.

Research Applications

Researchers often study CJC-1295 alongside GHRPs such as Ipamorelin to examine how separate GH-secretagogue pathways interact. That use pattern is best described as a research convention, not a validated clinical protocol.

Use CJC-1295 (With DAC) in the peptide calculator

This opens the current supported deep-link flow. Treat the preselected math as a starting point only, then adjust vial amount, reconstitution volume, and target amount to match your actual setup.

Use in Calculator

Expanded Research Context

CJC-1295 (With DAC) in context: CJC-1295 (With DAC) sits in the GHRH branch, where interpretation usually depends on peptide-specific analog design and whether the evidence is mechanistic, trial-based, or a practical handling extrapolation. This profile currently links 1 direct study reference, led by Pulsatile secretion of growth hormone (GH) persisted during continuous GHRH administration (2006).

What researchers usually look for on this page: The main research-interest signals surfaced here are Increased growth hormone levels, GH-axis research interest, Recovery research interest. Those bullets should be read as topic clusters and literature themes, not as proof that every claimed effect is equally established across formulations, routes, or study populations.

Evidence ceiling: This page is currently best treated as moderate-confidence evidence with meaningful interpretation limits. The listed stability class is Standard, which helps with planning and internal consistency, but any duration or decay implication that is not directly tied to a label or linked paper should still be treated as conservative handling guidance rather than assay-proven shelf life.

Handling And Interpretation Notes

Reconstitution logic: Reconstitute with Bacteriostatic Water. 2-3mL per 5mg vial is common. In practical terms, that instruction should be read as a starting workflow rather than a universal protocol. When a page mentions a solvent or a mixing style, the stronger claim is usually about keeping concentration math and contamination control consistent, not about one magic solvent making the peptide stable by itself.

Cold-storage reading: Stable for 4-5 weeks If the page does not cite a formulation-specific shelf-life study, the storage note should be read as cautious planning guidance. PeptideClock treats post-reconstitution freezing as a high-risk event for this page unless formulation-specific evidence says otherwise.

Room-temperature caution: Degrades rapidly at room temperature Even when a peptide is described as more robust than average, that usually means “less fragile than peers,” not “immune to handling mistakes.” Repeated warm exposure, poor labeling, and uncertain contamination history can still make the vial a discard candidate before any visual defect appears.

Risk Framing And Next Questions

Tolerability language on this page: Headache, Flushing, Injection site reactions. These items are here to keep the page evidence-aware, especially where small studies, mechanistic papers, or legacy bioregulator literature might otherwise tempt broader safety conclusions than the sources support.

Interpretation note: CJC-1295 (With DAC) still needs the same evidence discipline as higher-risk compounds: keep label-backed facts, peer-reviewed findings, and PeptideClock model estimates separate.

  • Use the linked study section to anchor the strongest claim on the page before treating a benefit bullet as established.
  • Use the calculator and storage tools for math and planning, not to upgrade weak evidence into stronger biological certainty.
  • If a practical handling question depends on the exact formulation, route, or solvent, treat the answer as unresolved until the page links direct evidence for that exact setup.

What Raises Or Lowers Confidence

Confidence driver: This page has at least one direct study anchor, which is useful, but one citation rarely answers every practical handling question on its own.

What lowers confidence fastest: The biggest downgrade usually comes from mixing evidence types together. A page becomes easier to misread when label-backed facts, peer-reviewed findings, mechanism-only reasoning, and PeptideClock estimates are treated as interchangeable support.

What would strengthen this page: Direct formulation-matched stability studies, clearer route-specific data, and replicated human evidence would improve how much of the page can be read as established instead of provisional. The next useful question is usually which claim on the page is directly supported by linked evidence and which part remains a cautious planning estimate.

  • Prefer the linked study section over family-level reputation when weighing a specific benefit claim.
  • Treat room-temperature and post-reconstitution handling as the least transferable claims unless directly studied.
  • Use the confidence badge as a ceiling on certainty, not as a reason to ignore the page's stated limits.

Profile Reading Checklist

If you are using this profile to answer a practical research question, move through the page in order rather than jumping straight from the name to the calculator or the benefit list. That keeps the strongest evidence, the handling assumptions, and the model estimates in the correct order.

  1. Confirm whether the strongest claim you care about is supported by a linked study or only by family-level context.
  2. Match the storage and reconstitution notes to your exact material state: lyophilized powder, recently mixed vial, or repeatedly accessed solution.
  3. Separate biological interest from workflow certainty. A peptide can be interesting mechanistically while still having thin practical handling evidence.
  4. Use tools on the site for math and tracking only after deciding that the underlying evidence question has been framed correctly.

Evidence & Interpretation

What this page can support: 1 linked study on page, led by Pulsatile secretion of growth hormone (GH) persisted during continuous GHRH administration (2006).

Family context: GHRH analog pages should be read through the lens of GH pulsatility research, analog-specific pharmacology, and cautious handling assumptions once reconstituted.

How to read the page: The most useful questions on these pages are usually about evidence quality, dosing logic in the literature, and whether the compound behaves like a fragile solution or a more stable lyophilized powder.

Stability interpretation: CJC-1295 (With DAC) is modeled as standard stability with medium confidence. Handling assumptions remain conservative once material is reconstituted.

Freeze handling note: PeptideClock treats reconstituted material as a do-not-freeze case unless direct formulation evidence says otherwise.

Important limit: Any storage window, room-temperature note, or solvent implication on this page should be treated as formulation-specific evidence only when a linked study or product label directly supports it. Otherwise it is conservative handling guidance or a PeptideClock model-based planning aid.

Practical Research Planning

Research question this page is best forMechanism, evidence strength, and conservative handling expectations for CJC-1295 (With DAC) rather than treatment claims.
Best source type on pageDirect linked study or trial citation
Reconstitution takeawayReconstitute with Bacteriostatic Water. 2-3mL per 5mg vial is common.
Cold-storage takeawayStable for 4-5 weeks
Room-temperature cautionDegrades rapidly at room temperature

How To Use This Profile

  1. Start with the study links and confidence badge before treating any benefit statement as settled.
  2. Use the storage and room-temperature notes as planning guidance, then verify whether your exact formulation matches the evidence source.
  3. Open the Potency Decay Calculator if you need a date-based estimate for this peptide's handling scenario.
  4. Read storage, dosing, or pharmacology claims alongside the site's research disclaimer, especially for high-risk or label-backed compounds.

Clinical Data & Studies

Evidence basis: The linked studies support the page's direct literature claims. They do not automatically validate every practical storage or dosing assumption for non-matching formulations.

Model note: When the calculator or stability copy goes beyond a direct study or label, PeptideClock treats those numbers as conservative planning estimates rather than assay-proven endpoints.

Researched Effects

  • Increased growth hormone levels
  • GH-axis research interest
  • Recovery research interest
  • Sleep-related research interest

Potential Side Effects

  • Headache
  • Flushing
  • Injection site reactions

Stability Profile

Fridge (2-8°C)

Stable for 4-5 weeks

Room Temp

Degrades rapidly at room temperature